K7I

General Information


DRACP ID  DRACP02638

Peptide Name   K7I

Sequence  IKPIIKPIIKPIIKPIIKPIIKPIIKPI

Sequence Length  28

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP Membrane lysis



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
RAW 264.7 Mouse leukemia Leukemia IC50=2749 µM MTT assay 18-24 h 1

Hemolytic Activity  Human erythrocytes: HC10>128 µM

Normal (non-cancerous) Cytotoxicity  HEK 293T: IC50=5921 μM

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  DRACP02638

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C161H289N35O29

Absent amino acids  ACDEFGHLMNQRSTVWY

Common amino acids  I

Mass  366108

Pl  11.58

Basic residues  7

Acidic residues  0

Hydrophobic residues  14

Net charge  7

Boman Index  3003

Hydrophobicity  87.5

Aliphatic Index  195

Half Life 
  Mammalian: 30 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  0

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 30742437

Title  Antimicrobial Peptides with High Proteolytic Resistance for Combating Gram-Negative Bacteria

Doi 10.1021/acs.jmedchem.8b01348

Year  2019

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.